Results 201 to 210 of about 2,158,802 (336)
Sobre una forma inédita de la primera persona del singular transitivo, en Urrizola-Galain (Ulzama)
Txepetx
openalex +2 more sources
Configuración De La Persona En La Poesía Religiosa Del XVII: Lope De Vega Y Miguel De Barrios [PDF]
Harm den Boer
openalex +1 more source
El debat sobre nacionalisme sembla prendre relleu i actualitat. Amb la desaparició dels condicionaments igualitaris a l'est d'Europa, ha tingut lloc un ressorgiment dels diferents pobles amb les seves reivindicacions. Les nacions sense Estat, en el nostre àmbit reclamen una Europa dels Pobles.
openaire +3 more sources
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain+3 more
wiley +1 more source
Bilingual Dialogue Dataset with Personality and Emotion Annotations for Personality Recognition in Education. [PDF]
Liu Z, Xiao Y, Su Z, Ye L, Lu K, Peng X.
europepmc +1 more source
Antropometría y composición corporal en personas mayores de 60 años. Importancia de la actividad física [PDF]
Heliodoro Alemán-Mateo+2 more
openalex +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source